Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

BACKGROUND: Adjuvant endocrine therapy undoubtedly prolongs the time to recurrence for patients with hormone-positive early breast cancer. Extended endocrine therapy to 10 years or longer has been expected to bring a greater clinical advantage. However, the related research conclusions are controver...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Li, Li, Chang, Bingmei, Jiang, Xiaoyue, Fan, Xueke, Li, Yingrui, Li, Teng, Wu, Shanshan, Zhang, Jun, Kariminia, Seyed, Li, Qin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186070/
https://ncbi.nlm.nih.gov/pubmed/30314452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4878-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak